Adrenal myelolipomas

J Calissendorff, CC Juhlin, A Sundin… - The lancet Diabetes & …, 2021 - thelancet.com
Adrenal myelolipomas are benign, lipomatous tumours with elements of myeloid cells, most
of which present as adrenal incidentalomas and comprise 3· 3–6· 5% of all adrenal masses …

The many facets of erythropoietin physiologic and metabolic response

S Suresh, PK Rajvanshi, CT Noguchi - Frontiers in physiology, 2020 - frontiersin.org
In mammals, erythropoietin (EPO), produced in the kidney, is essential for bone marrow
erythropoiesis, and hypoxia induction of EPO production provides for the important …

Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury

ML Brines, P Ghezzi, S Keenan… - Proceedings of the …, 2000 - National Acad Sciences
Erythropoietin (EPO), recognized for its central role in erythropoiesis, also mediates
neuroprotection when the recombinant form (r-Hu-EPO) is directly injected into ischemic …

The retinal pigment epithelium: something more than a constituent of the blood‐retinal barrier—implications for the pathogenesis of diabetic retinopathy

R Simó, M Villarroel, L Corraliza… - BioMed Research …, 2010 - Wiley Online Library
The retinal pigment epithelium (RPE) is an specialized epithelium lying in the interface
between the neural retina and the choriocapillaris where it forms the outer blood‐retinal …

Lineage-specific hematopoietic growth factors

K Kaushansky - New England Journal of Medicine, 2006 - Mass Medical Soc
Lineage-Specific Hematopoietic Growth Factors | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

[HTML][HTML] Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes

LA Szczech, HX Barnhart, JK Inrig, DN Reddan… - Kidney international, 2008 - Elsevier
Trials of anemia correction in chronic kidney disease have found either no benefit or
detrimental outcomes of higher targets. We did a secondary analysis of patients with chronic …

Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells

T Shingo, ST Sorokan, T Shimazaki… - Journal of …, 2001 - Soc Neuroscience
Recent studies have shown that neurogenesis is enhanced after hypoxia and that
erythropoietin (EPO), an inducible cytokine, is produced in the brain as part of the intrinsic …

Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury

Z Cai, DJ Manalo, G Wei, ER Rodriguez, K Fox-Talbot… - Circulation, 2003 - Am Heart Assoc
Background—Preconditioning phenomena provide evidence for adaptive responses to
ischemia that have important implications for treatment/prevention of myocardial infarction …

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury

AK Junk, A Mammis, SI Savitz… - Proceedings of the …, 2002 - National Acad Sciences
Erythropoietin (EPO) plays an important role in the brain's response to neuronal injury.
Systemic administration of recombinant human EPO (rhEPO) protects neurons from injury …

Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention

PW Lin, TR Nasr, BJ Stoll - Seminars in perinatology, 2008 - Elsevier
Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality among infants
in the neonatal intensive care unit. Here we review the epidemiology and pathophysiology …